Sun, Jan 07, 2024
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for "presence of foreign tablets/capsules" in the affected lot.
More >
Tue, Jul 25, 2023
Dr Reddy's Labs is scheduled to report its financial results for the June quarter on July 26. Analysts expect DRLto stage a strong quarterly performance driven by growing demand and improving margin.
Thu, Jul 20, 2023
Dr Reddy's Labs shares scaled a 52-week high on Thursday after the drug maker said the US regulator completed an inspection at its Srikakulam API facility without any observation.
Tue, Jan 24, 2023
Both auto companies are likely to report healthy Q3 earnings helped by easing in raw materials prices, higher realisations and healthy demand during the reporting quarter.
Mon, Nov 14, 2022
The broader markets such as Nifty Midcap and Smallcap outperformed the benchmarks to end nearly 0.06 and 0.5 per cent higher, respectively, on Monday.
Fri, Jul 29, 2022
Zee Business brings you a list of 20 stocks from cash, techno, and F&O space. These stocks have been picked keeping in view investors' short-to-long term requirements.
Fri, Jul 08, 2022
Brokerage Report are bullish on these top 5 Stocks. Brokerage house give target price for the investors, in this video know which stocks you may add in your portfolio
Fri, Jun 24, 2022
Global brokerage are bullish and giving buy rating on these top 5 stocks in share market. If You are willing to add these stocks in your portfolio see full video here
Mon, Nov 01, 2021
Global brokerage firms such as Macquarie, Nomura, CLSA, as well as JPMorgan tweaked their target price on companies post September quarter results.
Mon, Jun 18, 2018
Shares of Vedanta and Dr Reddy's Labs fell up to 4 per cent after the 30 shares on benchmark Sensex got reshuffled with some exlusion and inclusion with effect from Monday. Under the reconstitution, Vedanta entered the benchmark index, while Dr Reddy's Labs exited the index.
Fri, Nov 04, 2016
Indian shares fell to their lowest in nearly four months on Friday, led by drug makers, after Bloomberg reported that US prosecutors could file charges by year-end in a criminal investigation of generic makers over suspected price collusion.
Tue, Oct 25, 2016
Dr Reddy's Laboratories today reported a decline of 60.12 per cent in consolidated net profit for the September quarter at Rs 308.9 crore, mainly because of drop in sales in Venezuela and North America.
Wed, Aug 31, 2016
Following the FDC ban, this market fell by 3.9% to Rs 234 crore in the given quarter. Whereas drugs under NLEM grew by 1.6% to Rs 1061 crore, while non-NLEM drugs posted growth of 11.2% to Rs 7677 crore.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
